Evaluation of pdgf-ab, pdgf-bb, tgf- α, EGF and ang-2 as potential biomarkers in the diagnosis of endometrial cancer

This study aimed to investigate whether PDGF-AB, PDGF-BB, TGF- α, EGF, and ANG-2 could be considered as new useful markers for diagnosis of endometrial cancer. 93 women diagnosed with endometrial cancer (EC) and 66 patients with non-cancerous endometrial lesions (NCEL) were included in this study. The preoperative plasma PDGF-AB, PDGF-BB, TGF-α, EGF, and ANG- 2 levels were determined by a enzyme-linked immunosorbent assay (SunRed Biotechnology, Shanghai) according to the manufacturer’s protocol.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Source Type: research